首页> 外文期刊>Advanced Science >Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1
【24h】

Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1

机译:滋生1-富集的细胞外囊囊泡通过激活肺成纤维细胞分泌肿瘤坏死因子受体1,促进肝癌的脱毛转移

获取原文
           

摘要

In hepatocellular carcinoma (HCC) patients with extrahepatic metastasis, the lung is the most frequent site of metastasis. However, how the lung microenvironment favors disseminated cells remains unclear. Here, it is found that nidogen 1 (NID1) in metastatic HCC cell‐derived extracellular vesicles (EVs) promotes pre‐metastatic niche formation in the lung by enhancing angiogenesis and pulmonary endothelial permeability to facilitate colonization of tumor cells and extrahepatic metastasis. EV‐NID1 also activates fibroblasts, which secrete tumor necrosis factor receptor 1 (TNFR1), facilitate lung colonization of tumor cells, and augment HCC cell growth and motility. Administration of anti‐TNFR1 antibody effectively diminishes lung metastasis induced by the metastatic HCC cell‐derived EVs in mice. In the clinical perspective, analysis of serum EV‐NID1 and TNFR1 in HCC patients reveals their positive correlation and association with tumor stages suggesting the potential of these molecules as noninvasive biomarkers for the early detection of HCC. In conclusion, these results demonstrate the interplay of HCC EVs and activated fibroblasts in pre‐metastatic niche formation and how blockage of their functions inhibits distant metastasis to the lungs. This study offers promise for the new direction of HCC treatment by targeting oncogenic EV components and their mediated pathways.
机译:在肝细胞癌(HCC)肝细胞癌患者中,肺部是最常见的转移位点。然而,肺部微环境有利于传播细胞仍然不清楚。在此,可知,巢蛋白1(NID1)在转移性HCC细胞来源的细胞外囊泡(EV)用通过增强血管发生和肺血管内皮细胞通透性,以促进肿瘤细胞和肝外转移的定殖促进了肺转移前利基形成。 EV-NID1还激活成纤维细胞,其分泌肿瘤坏死因子受体1(TNFR1),促进肿瘤细胞的肺部定植,并增加HCC细胞生长和运动性。抗TNFR1抗体的给药有效地减少了由小鼠中转移的HCC细胞衍生EV诱导的肺转移。在临床观点中,HCC患者血清EV-NID1和TNFR1分析揭示了它们与肿瘤阶段的阳性相关性和关联,表明这些分子作为非侵入性生物标志物的潜力,用于早期检测HCC。总之,这些结果证明了HCC EVS和活化成纤维细胞在预转移性乳头形成中的相互作用以及如何障碍它们的功能抑制远处转移到肺部。本研究提供了通过靶向致癌的EV组分及其介导的途径来提供HCC治疗的新方向的承诺。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号